Infectious complications of immunosuppressive therapy in patients with rheumatic diseases

Rheumatic Disease Clinics of North America

Volumn 23, Issue 2, 1997, Pages 219-237

  Segal, B H ^a   Sneller, M C ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOCORTICOID; IMMUNOSUPPRESSIVE AGENT;

ARTICLE; BACTERIAL INFECTION; EARLY DIAGNOSIS; FEVER; HOST RESISTANCE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFECTION; INFECTIOUS COMPLICATION; INFLAMMATION; MORBIDITY; MORTALITY; OPPORTUNISTIC INFECTION; PRIORITY JOURNAL; RHEUMATIC DISEASE; RISK FACTOR; SYMPTOM;

EID: 0030989939     PISSN: 0889857X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0889-857X(05)70327-6     Document Type: Article

References (93)

1. N.I. Abdou B. Zweiman S.R. Casella Effects of azathioprine therapy on bone marrow–dependent and thymus-dependent cells in man Clin Exp Immunol 13 1973 55
2. A. Aboguddah H.B. Stein P. Phillips Herpes simplex hepatitis in a patient with psoriatic arthritis taking prednisone and methotrexate. Report and review of the literature J Rheumatol 18 1991 1406
3. G.L. Ackerman Alternate-day steroid therapy in lupus nephritis Ann Intern Med 72 1970 511
4. F.P. Alepa N.J. Zvaiffler A.J. Sliwinski Immunologic effects of cyclophosphamide treatment in rheumatoid arthritis Arthritis Rheum 13 1970 754
5. J.M. Anaya L. Diethelm L.A. Ortiz Pulmonary involvement in rheumatoid arthritis Semin Arthritis Rheum 24 1995 242
6. P.A. Andersen S.G. West J.R. O'Dell Weekly pulse methotrexate in rheumatoid arthritis. Clinical and immunologic effects in a randomized, double-blind study Ann Intern Med 103 1985 489
7. J.P. Atkinson M.M. Frank Complement-independent clearance of IgG-sensitized erythrocytes: Inhibition by cortisone Blood 44 1974 629
8. H.A. Austin 3d J.H. Klippel J.E. Balow Therapy of lupus nephritis: Controlled trial of prednisone and cytotoxic drugs N Engl J Med 314 1986 614
9. T.R. Bachman A.D. Sawitzke S.L. Perkins Methotrexate-associated lymphoma in patients with rheumatoid arthritis: Report of two cases Arthritis Rheum 39 1996 325
10. J.B. Bass Jr L.S. Farer P.C. Hopewell Treatment of tuberculosis infection in adults and children. American Thoracic Society and the Centers for Disease Control and Prevention Am J Respir Crit Care Med 149 1994 1359
11. M.J. Bell L.W. Martin L.L. Gonzales Alternate-day single-dose prednisone therapy: A method of reducing steroid toxicity J Pediatr Surg 7 1972 223
12. B. Beutler N. Krochin I.W. Milsark Control of cachectin (tumor necrosis factor) synthesis: Mechanisms of endotoxin resistance Science 232 1986 977
13. A.M.T. Boerbooms P.J. Kerstens J.W. van Loenhout Infections during low-dose methotrexate treatment in rheumatoid arthritis Semin Arthritis Rheum 24 1995 411
14. D.L. Bowen A.S. Fauci Adrenal corticosteroids J.I. Gallin I. Goldstein R. Snyderman Inflammation: Basic Principles and Clinical Correlates 1988 Raven Press New York 877
15. J.D. Bradley K.D. Brandt B.P. Katz Infectious complications of cyclophosphamide treatment for vasculitis Arthritis Rheum 32 1989 45
16. W.T. Butler R.D. Rossen Effects of corticosteroids on immunity in man. I. Decreased serum IgG concentration caused by 3 to 5 days of high doses of methylprednisolone J Clin Invest 52 1973 2629
17. L.H. Calabrese Vasculitis of the central nervous system Rheum Dis Clin North Am 21 1995 1059
18. S. Carette J.H. Klippel J.L. Decker Controlled studies of oral immunosuppressive drugs in lupus nephritis. A long-term follow-up Ann Intern Med 99 1983 1
19. Cooperating Clinics Committee of the American Rheumatism Association A controlled trial of cyclophosphamide in rheumatoid arthritis N Engl J Med 283 1970 883
20. B.N. Cronstein A novel approach to the development of anti-inflammatory agents: Adenosine release at inflamed sites J Investig Med 43 1995 50
21. T.R. Cupps L.C. Edgar A.S. Fauci Suppression of human B-lymphocyte function by cyclophosphamide J Immunol 128 1982 2453
22. T.R. Cupps L.C. Edgar C.A. Thomas Multiple mechanisms of B-cell immunoregulation in man after administration of in vivo corticosteroids J Immunol 132 1984 170
23. D.C. Dale A.S. Fauci D. Guerry IV Comparison of agents producing a neutrophilic leukocytosis in man. Hydrocortisone, prednisone, endotoxin, and etiocholanolone J Clin Invest 56 1975 808
24. D.C. Dale A.S. Fauci S.M. Wolff Alternate-day prednisone. Leukocyte kinetics and susceptibility to infections N Engl J Med 291 1974 1154
25. D.C. Dale A.S. Fauci S.M. Wolff The effect of cyclophosphamide on leukocyte kinetics and susceptibility to infections in patients with Wegener's granulomatosis Arthritis Rheum 16 1973 657
26. J.V. Donadio Jr K.E. Holley R.H. Ferguson Treatment of diffuse proliferative lupus nephritis with prednisone and combined prednisone and cyclophosphamide N Engl J Med 299 1977 1151
27. K.N. Duffy C.M. Duffy D.D. Gladman Infection and disease activity in systemic lupus erythematosus: A review of hospitalized patients J Rheumatol 18 1991 1180
28. A.S. Fauci Alternate-day corticosteroid therapy Am J Med 64 1978 729
29. A.S. Fauci D.C. Dale The effect of in vivo hydrocortisone on subpopulations of human lymphocytes J Clin Invest 53 1974 240
30. A.S. Fauci D.C. Dale J.E. Balow Glucocorticosteroid therapy: Mechanisms of action and clinical considerations Ann Intern Med 84 1976 304
31. A.S. Fauci D.C. Dale S.M. Wolff Cyclophosphamide and lymphocyte subpopulations in Wegener's granulomatosis Arthritis Rheum 17 1974 355
32. A.S. Fauci B.F. Haynes P. Katz Wegener's granulomatosis: Prospective clinical and therapeutic experience with 85 patients for 21 years Ann Intern Med 98 1983 76
33. A.S. Fauci K.R. Young Immunoregulatory agents W. Kelley E. Harris S. Ruddy Textbook of Rheumatology ed 4 1993 WB Saunders Company Philadelphia 797
34. E.J. Feinglass F.C. Arnett C.A. Dorsch Neuropsychiatric manifestations of systemic lupus erythematosus: Diagnosis, clinical spectrum, and relationship to other features of disease Medicine 55 1976 323
35. C. Fournier M.A. Bach M. Dardenne Selective action of azathioprine on T cells Transplant Proc 5 1973 523
36. D.E. Furst N. Erikson L. Clute Adverse experience with methotrexate during 176 weeks of a long-term prospective trial in patients with rheumatoid arthritis J Rheumatol 17 1990 1628
37. J.I. Gallin E.S. Buescher B.E. Seligmann NIH conference. Recent advances in chronic granulomatous disease Ann Intern Med 99 1983 657
38. A.E. Gassmann R. van Furth The effect of azathioprine (Imuran) on the kinetics of monocytes and macrophages during the normal steady state and an acute inflammatory reaction Blood 46 1975 51
39. J.G. Gerrard Pneumocystis carinii pneumonia in HIV-negative immunocompromised adults Med J Aust 162 1995 233
40. V.J. Gill Laboratory evaluation of specimens. In Shelhamer JH (moderator): The laboratory evaluation of opportunistic pulmonary infections Ann Intern Med 124 1996 586 588
41. E. Ginzler H. Diamond D. Kaplan Computer analysis of factors influencing frequency of infection in systemic lupus erythematosus Arthritis Rheum 21 1978 37
42. J.G. Gispen G.S. Alarcon J.J. Johnson Toxicity to methotrexate in rheumatoid arthritis J Rheumatol 14 1987 74
43. B. Godeau V. Coutant-Perronne D.L.T. Huong Pneumocystis carinii pneumonia in the course of connective tissue disease: Report of 34 cases J Rheumatol 21 1994 246
44. J.A. Govert S. Patton R.L. Fine Pancytopenia from using trimethoprim and methotrexate Ann Intern Med 117 1992 877
45. L. Gruberg M. Thaler J. Rozenman Nocardia asteroides infection complicating rheumatoid arthritis J Rheumatol 18 1991 459
46. D.B. Hellmann M. Petri Q. Whiting-O'Keefe Fatal infections in systemic lupus erythematosus: The role of opportunistic infections Medicine 66 1987 341
47. M. Ho Cytomegalovirus G.L. Mandell J.E. Bennett R. Dolin Principles and Practice of Infectious Diseases ed 4 1995 Churchill Livingstone New York 1351
48. G.S. Hoffman G.S. Kerr R.Y. Leavitt Wegener's granulomatosis: An analysis of 158 patients Ann Intern Med 116 1992 488
49. W.T. Hughes G.K. Rivera M.J. Schell Successful intermittent chemoprophylaxis for Pneumocystis carinii pneumonitis N Engl J Med 316 1987 1627
50. H. Jonsson O. Nived G. Sturfelt Outcome in systemic lupus erythematosus: A prospective study of patients from a defined population Medicine 68 1989 141
51. O.W. Kamel M. van de Rijn L.M. Weiss Brief report: Reversible lymphomas associated with Epstein-Barr virus occurring during methotrexate therapy for rheumatoid arthritis and dermatomyositis N Engl J Med 328 1993 1317
52. J.M. Keegan J.W. Byrd Nocardiosis associated with low-dose methotrexate for rheumatoid arthritis J Rheumatol 15 1988 1585
53. P.J. Knudsen C.A. Dinarello T.B. Strom Glucocorticosteroids inhibit transcriptional and posttranscriptional expression of interleukin 1 in U937 cells J Immunol 139 1987 4129
54. K.J. Kwon-Chung J.E. Bennett Candidiasis Medical Mycology 1992 Lea and Febiger Philadelphia 280
55. J. Levy E.V. Barnett N.S. MacDonald The effect of azathioprine on gamma globulin synthesis in man J Clin Invest 51 1972 2233
56. R.R. MacGregor J.N. Sheagren M.B. Lipsett Alternate-day prednisone therapy. Evaluation of delayed hypersensitivity responses, control of disease, and steroid side effects N Engl J Med 280 1969 1427
57. H.I. Maibach W.L. Epstein Immunologic responses of healthy volunteers receiving azathioprine (Imuran) Int Arch Allergy Immunol 27 1965 102
58. H. Masur Prevention and treatment of pneumocystis pneumonia N Engl J Med 327 1992 1853
59. W.J. McCune J. Golbus W. Zeldes Clinical and immunologic effects of monthly administration of intravenous cyclophosphamide in severe systemic lupus erythematosus N Engl J Med 318 1988 1423
60. J.R. Mera E. Whimbey L. Elting Cytomegalovirus pneumonia in adult nontransplantation patients with cancer: Review of 20 cases occurring from 1964–1990 Clin Infect Dis 22 1996 1046
61. P.M. Moore T.R. Cupps Neurologic complications of vasculitis Ann Neurol 14 1983 155
62. H. Nishino F.A. Rubino R.A. DeRemee Neurologic involvement in Wegener's granulomatosis: An analysis of 324 consecutive patients at the Mayo Clinic Ann Neurol 33 1993 4
63. F.P. Ognibene J.H. Shelhamer G.S. Hoffman Pneumocystis carinii pneumonia: A major complication of immunosuppressive therapy in patients with Wegener's granulomatosis Am J Respir Crit Care Med 151 1995 795
64. N.J. Olsen L.F. Callahan T. Pincus Immunologic studies of rheumatoid arthritis patients treated with methotrexate Arthritis Rheum 30 1987 481
65. I.L. Paradis W.F. Grugurich J.S. Drummer Rapid detection of cytomegalovirus pneumonia from lung lavage cells Am Rev Respir Dis 138 1988 697
66. M.A. Pohl S.P. Lan T. Berl Plasmapheresis does not increase the risk for infection in immunosuppressed patients with severe lupus nephritis Ann Intern Med 114 1991 924
67. A.J. Porges S.L. Beattie C. Ritchlin Patients with systemic lupus erythematosus at risk for Pneumocystis carinii pneumonia J Rheumatol 19 1992 1191
68. J.J. Rinehart S.P. Balcerzak A.L. Sagone Effects of corticosteroids on human monocyte function J Clin Invest 54 1974 1337
69. S. Rosner E.M. Ginzler H.S. Diamond A multicenter study of outcome in systemic lupus erythematosus: II. Causes of death Arthritis Rheum 25 1982 612
70. S.L. Schreiber G.R. Crabtree The mechanism of action of cyclosporin A and FK506 Immunol Today 13 1992 136
71. P.H. Schur Clinical features of SLE W.N. Kelly E.D. Harris S. Ruddy C.B. Sledge Textbook of Rheumatology ed 4 1993 WB Saunders Philadelphia 1017
72. R.J. Sharbaugh S.K. Ainsworth C.T. Fitts Lack of effect of azathioprine on phytohemagglutinin-induced lymphocyte transformation and established delayed cutaneous hypersensitivity Int Arch Allergy Immunol 51 1976 681
73. Y. Shoenfeld Y. Gurewich L.A. Gallant Prednisone-induced leukocytosis. Influence of dosage, method, and duration of administration on the degree of leukocytosis Am J Med 71 1981 773
74. J.T. Sibley W.P. Olszynski W.E. Decoteau The incidence and prognosis of central nervous system disease in systemic lupus erythematosus J Rheumatol 19 1992 47
75. R.R. Siegel R.G. Luke A.A. Hellebusch Reduction of toxicity of corticosteroid therapy after renal transplantation Am J Med 53 1972 159
76. L.H. Sigal The neurologic presentation of vasculitis and rheumatologic syndromes. A review Medicine 66 1987 157
77. G. Singh J.F. Fries C.A. Williams Toxicity profiles of disease-modifying antirheumatic drugs in rheumatoid arthritis J Rheumatol 18 1991 188
78. K. Skogberg P. Ruutu P. Tukiainen Effect of immunosuppressive therapy on the clinical presentation and outcome of tuberculosis Clin Infect Dis 17 1993 1012
79. J.D. Smith J.M. Knox Psoriasis, methotrexate, and tuberculosis Br J Dermatol 84 1971 590
80. M.C. Sneller G.S. Hoffman C. Talar-Williams An analysis of forty-two Wegener's granulomatosis patients treated with methotrexate and prednisone Arthritis Rheum 38 1995 608
81. N.I. Stahl J.H. Klippel J.L. Decker Fever in systemic lupus erythematosus Am J Med 67 1979 935
82. P.J. Staples D.N. Gerding J.L. Decker Incidence of infection in systemic lupus erythematosus Arthritis Rheum 17 1974 1
83. A.E. Stuck C.E. Minder F.J. Frey Risk of infectious complications in patients taking glucocorticosteroids Rev Infect Dis 11 1989 954
84. A.F. Suffredini Diagnosis of infection: Noninvasive and invasive procedures. In Shelhamer JH (moderator): Respiratory disease in the immunocompromised patient Ann Intern Med 117 1992 420 422
85. E.J. ter Borg G. Horst P.C. Limburg C-reactive protein levels during disease exacerbations and infections in systemic lupus erythematosus: A prospective longitudinal study J Rheumatol 17 1990 1642
86. M. Thomas L.A. Gutterman Methotrexate toxicity in a patient receiving trimethoprim-sulfamethoxazole J Rheumatol 13 1986 440
87. M.E. Weinblatt Methotrexate W. Kelley E. Harris S. Ruddy Textbook of Rheumatology ed 4 1993 WB Saunders Company Philadelphia 767
88. L.A. Witty F. Steiner M. Curfman Disseminated histoplasmosis in patients receiving low-dose methotrexate for psoriasis Arch Dermatol 128 1992 91
89. K.L. Wong E.K.W. Woo Y.L. Yu Neurologic manifestations of systemic lupus erythematosus: A prospective study QJM 81 1991 857
90. S.H. Yale A.H. Limper Pneumocystis carinii pneumonia in patients without acquired immunodeficiency syndrome: Associated illness and prior corticosteroid therapy Mayo Clin Proc 71 1996 5
91. D.T. Yu P.J. Clements J.B. Peter Lymphocyte characteristics in rheumatic patients and the effect of azathioprine therapy Arthritis Rheum 17 1974 37
92. V.L. Yu R.R. Muder A. Poorsattar Significance of isolation of Aspergillus from the respiratory tract in diagnosis of invasive pulmonary aspergillosis. Results from a 3-year prospective study Am J Med 81 1986 249
93. L.P. Zhu T.R. Cupps G. Whalen Selective effects of cyclophosphamide therapy on activation, proliferation, and differentiation of human B cells J Clin Invest 79 1987 1082